Action 600380 JOINCARE PHARMACEUTICAL GROUP INDUSTRY CO.,LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Joincare Pharmaceutical Group Industry Co.,Ltd.

Actions

600380

CNE000001816

Cours en clôture Shanghai S.E.
Autres places de cotation
 00:00:00 16/05/2024 		Varia. 5j. Varia. 1 janv.
12,86 CNY -0,92% Graphique intraday de Joincare Pharmaceutical Group Industry Co.,Ltd. +1,26% +3,46%
25/04 Joincare Pharmaceutical Group Industry Co. Ltd. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 présente ses résultats pour le premier trimestre clos le 31 mars 2024 CI
18/04 Joincare Pharmaceutical achève avec succès l'étude de phase III TG-1000 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Joincare Pharmaceutical Group Industry Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Joincare Pharma Says Flu Drug Phase 3 Trial Attains Primary Endpoint
Joincare Pharmaceutical Successfully Completes TG-1000 Phase III Study
Joincare Pharmaceutical Group's 2023 Profit Falls 4%; Shares Slide 4%
Joincare Pharmaceutical Group Industry Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Livzon Pharma to Trial JP-1366 Tablets as Reflux Esophagitis Drug
Livzon Pharmaceutical Appoints Former Joincare Exec as Vice President
Boan Biotechnology, Joincare Sign Exclusive License Deal for Respiratory Disease Treatment
Shandong Boan Biotechnology Co., Ltd. Enters into Agreement with Joincare Pharmaceutical Group Industry Co., Ltd
Joincare Pharmaceutical, Guangzhou Fermion Technology Get Nod to Trial Analgesic Drug
Livzon Pharmaceutical to Continue Getting Services from Joincare Pharmaceutical
Joincare Pharma’s 210 Drugs Included in China's Medical Insurance Catalog
Joincare Gets Nod to Trial Pain Relief Drug
Joincare Pharma Shortlisted For China’s Drug Procurement Program
Tranche Update on Joincare Pharmaceutical Group Industry Co.,Ltd.'s Equity Buyback Plan announced on December 15, 2022.
Joincare Pharmaceutical Group Industry Co.,Ltd.'s Equity Buyback announced on December 15, 2022 has closed with 49,706,643 shares, representing 2.61% for CNY 599.91 million.
Joincare Pharmaceutical Group Industry Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Joincare Pharma Unit Gets Go Signal from China for Phase 3 Trial of Endometriosis Drug
Tranche Update on Joincare Pharmaceutical Group Industry Co.,Ltd.'s Equity Buyback Plan announced on December 15, 2022.
Joincare Pharmaceutical Group Industry Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 600380
  4. Actualités Joincare Pharmaceutical Group Industry Co.,Ltd.
  5. Autres langues